Categories
Science

“The people who find themselves producing these [CO2] emissions must … pay the worth” – Watts Up With That?

Essay by Eric Worrall

Exxon CEO Darren Woods has incensed greens by suggesting end users are responsible for generating emissions.

Fury after Exxon chief says public to blame for climate failures

Darren Woods tells Fortune consumers not willing to pay for clean-energy transition, prompting backlash from climate experts

The world is off track to meet its climate goals and the public is to blame, Darren Woods, chief executive of oil giant ExxonMobil, has claimed – prompting a backlash from climate experts.

As the world’s largest investor-owned oil company, Exxon is among the top contributors to global planet-heating greenhouse gas emissions. But in an interview, published on Tuesday, Woods argued that big oil is not primarily responsible for the climate crisis.

The real issue, Woods said, is that the clean-energy transition may prove too expensive for consumers’ liking.

The dirty secret nobody talks about is how much all this is going to cost and who’s willing to pay for it,” he told Fortune last week. “The people who are generating those emissions need to be aware of and pay the price for generating those emissions. That is ultimately how you solve the problem.”

It’s like a drug lord blaming everyone but himself for drug problems,” said Gernot Wagner, a climate economist at Columbia business school.

Wagner said that Exxon was touting its ambition to slash the emissions of its own operations while also betting that the rest of the world won’t do the same, in order to continue selling oil.

“He can’t have it both ways in saying ‘we are an energy company’ but then basically ignoring the cheapest source of electricity in history as something Exxon should be investing in,” he said.

Read more: https://www.theguardian.com/us-news/2024/mar/04/exxon-chief-public-climate-failures

A video of CEO Darren Woods being interviewed by Fortune Magazine.

The “Dirty Secret” comments are made around 18:43. Woods also said that “Today’s technology will not solve this problem”, and emphasised the importance of getting the cost down, and the need for cost transparency with end users – and how important getting the cost down is for people’s willingness to pay for Net Zero.

Woods called for a carbon price (23:10 minutes).

30:55 “I will tell you today, there is not a viable market where consumers step in and are willing to pay a premium for low carbon products. That is the reality of what we face today. I can’t drive demand, and I can’t make consumers pay more for low carbon products”.

The big question – why are Greens so upset with what Exxon CEO Darren Woods said? Darren’s responses to questions in the video amounted to suggesting the government needs to do more to make low carbon options palatable, by putting a price on carbon, by supporting efforts to bring down the price of green solutions, or both.

I think what upset Greens is the Exxon CEO’s suggestion that Greens have to take personal responsibility for their piece of the Net Zero transition.

And of course, greens were likely upset by the Exxon CEOs suggestion that green energy is expensive – which contradicts Columbia Business School Gernot Wagner’s claim that Exxon is “ignoring [renewables] the cheapest source of electricity in history” – at least I presume he is talking about renewables.

Wagner’s inference that renewables are cheap is absurd.

Green energy is not cheap, it is hideously expensive. You just need to look at runaway energy prices in California and Europe, both champions of green energy, to know how expensive real world green energy is.

Even worse, the cost of energy in places like California and Europe is not a problem with implementation. Google admitted Net Zero is impossibly expensive in 2014, with an article published in Spectrum, about their failed attempt to discover an economically viable path to Net Zero. “Renewable energy technologies simply won’t work; we need a fundamentally different approach.“. The Google team failed to find an economically viable path to replacing coal with renewables, even when they added science fiction assumptions to their models, like wind towers which erect themselves without human assistance. The Google study authors were not advocating giving up, they were just saying more or less the same as Exxon CEO Darren Woods said in the video above. Today’s green energy technology is not a viable solution to the world’s energy needs.

Can you think of a more woke, leftist, green leaning company than Google? If even Google say green energy with current technology cannot work, perhaps Google are also part of Wagner’s conspiracy of energy company capitalists who are plotting to reduce their own profits?

Blaming Exxon, weaving bizarre big oil conspiracy theories, and responding with fury to the suggestion that greens themselves have to take personal responsibility – well I guess we’re all used to seeing that from greens.

We are also used to seeing lots of hypocrisy from greens. Greens have not exactly been champions of the lifestyle choices they want to inflict on everyone else, somehow the special people usually give themselves a moral pass from the rules they want to inflict on the rest of us.

I don’t know if Gernot Wagner is personally a green hypocrite, but plenty of his fellow travellers are. I mean, how often have we seen greens jetting off to climate conferences and making pathetic excuses for why they should be allowed to fly, while demanding everyone else have their flights rationed for the sake of the planet?

Who can forget embarrassing failures of greens to follow their own policy prescriptions, like the German Green Party’s hilariously expensive failure to install a functioning heat pump in their own headquarters, despite demanding Germany immediately pass laws which make such heat pumps mandatory for office buildings?

If Greens want the rest of us to even consider following their lead, they need to start practicing what they preach, by showing us through personal example that Net Zero is viable and affordable, instead of blaming others like Exxon CEO Darren Woods for their own personal failure to transition to a greener lifestyle.

Like this:

Like Loading…

Categories
Entertainment

Joe Manganiello Praises This Actress for “Ageing Backwards”

Joe Manganiello knows that Ming-Na Wen‘s reflection shows who she is inside.

The True Blood actor praised his longtime friend for “aging backwards” when the Mulan actress accepted the Timeless Beauty prize at the Hollywood Beauty Awards March 3.

“When you hear the phrase ‘timeless beauty,’ you think of someone frozen in time,” Manganiello shared on stage in Los Angeles. “But that’s just not the case with Ming.”

As he put it, “I can tell you firsthand that this isn’t a person frozen in time or a person who isn’t aging—this is someone who is aging backwards.” 

His proof? Well, Manganiello—who split with Sofía Vergara last year—has actually known Wen for many years, as they both attended Pittsburg’s Mt. Lebanon High School, as well as Carnegie Mellon University.

“I’ve seen Ming’s awkward high school photos from back when she was the president of the Science Fiction Fantasy Club,” Manganiello explained. “This is a person who keeps getting better looking as time goes on.”

Categories
Health

Change Healthcare new digital prescription device amid cyberattack

In this photo illustration, UnitedHealth Group Inc logo seen displayed on a tablet.

Igor Golovniov | Sopa Images | Lightrocket | Getty Images

Change Healthcare on Friday said it’s finished setting up a new electronic prescription service, which could help provide some relief to pharmacies and physicians that have been struggling to contend with the fallout from the ongoing cyberattack.

UnitedHealth Group, Change Healthcare’s parent company, is also launching a temporary funding assistance program to help providers manage their “short-term” cash flow needs, the company said.

UnitedHealth discovered that a cyber threat actor breached part of the unit’s information technology network on Feb. 21, according to a filing with the SEC. UnitedHealth isolated and disconnected the impacted systems “immediately upon detection” of the threat, the filing said, which has since caused ripples of disruption across the health-care system.

Change Healthcare offers tools for payment and revenue cycle management that help carry out transactions between providers and most major insurance companies. It also offers electronic prescription software.

In an update Friday, Change Healthcare said it has successfully tested a new version of its “Rx ePrescribing service” with vendors and retail pharmacy partners. The service was enabled for all customers starting at 2 p.m. ET on Friday, though the company added that its existing Clinical Exchange ePrescribing providers’ tools are still not working.

UnitedHealth also launched a website on Friday with information about Change Healthcare’s response to the attack. On the site, UnitedHealth said it’s establishing a temporary funding assistance program to help providers whose payment distributions have been interrupted.

The company said the program will have no fees, interest or other associated costs, and the funds will need to be repaid when standard operations resume. Providers can check their eligibility using a link through the new website.

“We understand the urgency of resuming payment operations and continuing the flow of payments through the health care ecosystem,” UnitedHealth said on the site.

The company added that the program is not meant for providers that are experiencing disruptions to their claims submissions. UnitedHealth recommends using manual workarounds for claims, and said it’s working to address the 15% of claims that workarounds cannot address.

UnitedHealth said late Monday night that more than 90% of the nation’s pharmacies had set up modified electronic claims processing workarounds, while the rest established offline processing systems. On Friday, the company said its data suggests pharmacy claims are “flowing at near-normal levels,” according to the new website.

Many of the company’s systems have been down for 10 straight days.

WATCH: ‘You can’t unscramble that egg’

Categories
Sport

European soccer information: Barca’s damage disaster, Man Metropolis beat Man United

De Jong and Pedri were removed in the first half with injuries as Barcelona drew with Athletic Club on Sunday. Alex Caparros/Getty Images

Another weekend of European football action is underway, and there was no shortage of drama everywhere you look. In Spain, Barcelona couldn’t take advantage of Real Madrid dropping points, drawing 0-0 with Athletic Club and now facing a nervous wait for news regarding the injuries to Frenkie De Jong and Pedri, both of whom left Sunday’s game in the first half.

In England, Man City eventually cracked derby rivals Man United with three second-half goals in a 3-1 win, Arsenal Women racked up an impressive win over Tottenham in the WSL, and PSV inched closer to the Eredivisie title with a 2-2 draw vs. Feyenoord.

– Stream on ESPN+: FA Cup, LaLiga, Bundesliga and more (U.S. only)

On Saturday, there was more referee drama in Spain, with Real Madrid, there were protests in Valencia, and there was vindication for Vinícius Júnior. Elsewhere, Luis Enrique stirred the pot quite considerably in Kylian Mbappé’s Paris Saint-Germain swan song, while Bayern Munich took another step toward coronating Bayer Leverkusen as Bundesliga champions.

Let’s get into the action.

SUNDAY REVIEW

The lead: Barça lament missed opportunity and injuries to De Jong and Pedri

Barcelona missed the chance to make up ground on LaLiga leaders Real Madrid as they were held to a goalless draw by Athletic Club at San Mamés on a night when they also lost Frenkie de Jong and Pedri to injuries.

Madrid’s draw at Valencia on Saturday had opened the door for Barça to move within six points of Los Blancos with 11 games to play. A win would also have taken them second in the table, ahead of Girona, who lost at Mallorca earlier on Sunday. Perhaps more significant than the dropped points was the loss of two key midfielders in the first half. De Jong was taken off on a stretcher after 26 minutes, having landed awkwardly on his ankle, while a muscle injury then forced Pedri off as well, just before the break.

Most worrying for Barça was the reaction of both players — Pedri was pictured in tears on the bench — and their injury histories this season. De Jong was sidelined for two months with an ankle sprain from September to November, while Pedri’s past three campaigns have seen repeated hamstring and thigh issues.

With Napoli due at the Olympic Stadium in the second leg of the Champions League round of 16 on March 12 — the first leg ended 1-1 in Italy — Barça are facing an injury crisis in midfield that could completely derail their season in Europe and domestically. Gavi has already been ruled out for the season with an ACL tear picked up while playing for Spain in November.

Without De Jong and Pedri, Barça struggled to get going against Athletic in a match of few real chances. Despite showing plenty of intensity, the hosts were also not at their best just three days after beating Atlético Madrid 3-0 to book their place in the Copa del Rey final.

“It’s a missed opportunity in all senses,” Barça coach Xavi Hernández said. “In terms of the performances, sensations, cutting the gap at the top. … We did not play well, we didn’t attack well and there is some sadness there because we were not at our best. The team was affected by the injuries.” — Marsden

Sunday talking points around the leagues

play

2:24

Can Man United take any positives from derby defeat vs. Man City?

Steve Nicol analyses Man United’s performance in their 3-1 loss against Man City.

Foden eclipses Rashford to seal Man City win

MANCHESTER, England — Phil Foden inspired Manchester City to a winning fightback against Manchester United as the Premier League champions responded to Liverpool’s late win at Nottingham Forest on Saturday to tee up a potential title decider at Anfield next week.

Marcus Rashford’s stunning opening goal — a 25-yard, right-footed rocket after hard work by Bruno Fernandes — gave United the lead at the Etihad and threatened to derail City’s hopes of becoming the first team in English football history to win four successive league titles. But two second-half strikes from Foden turned the game in City’s favour before Erling Haaland wrapped up a 3-1 victory with a goal from close range in stoppage time.

The win moves City to within a point of leaders Liverpool ahead of next Sunday’s meeting between the two sides. And although Arsenal can climb to within two points of Jurgen Klopp’s team by winning at Sheffield United on Monday, the Liverpool-City encounter is set to be the most significant game of the season so far, regardless of whether Arsenal claim top spot by beating Brentford at the Emirates on Saturday.

Foden’s contribution against United was decisive. The England international, a product of City youth system, scored a hat trick in this fixture last season and he haunted United again. His equalising goal, a curling effort from the edge of the penalty area, would normally have claimed the headlines for style but for Rashford’s remarkable shot.

Although United frustrated City for long periods, City’s registered 27 shots compared to three by United. Their dominance was clear and the win was fully deserved. — Ogden

Arsenal 1-0 Tottenham: North London left red after Russo’s rocket in marquee WSL game

LONDON — In their third meeting of the season, the actual football played between Arsenal and Spurs ended up as a footnote, with their flat encounter not quite living up to the billing as the Gunners claimed their first win in 90 minutes, 1-0, over their North London neighbours.

There was history made before anyone took to the pitch with the all-female ground staff who took care of the playing surface. Then there was the news of ticket sales: the match was the second successive Arsenal Women fixture at the Emirates that had been classed as a sellout, as well as the first North London Derby to sell out N7.

The game itself was not a classic, however; rather, it represented another step in Spurs’ evolution under Robert Vilahamn as his team sat and blocked for swathes of the game around attempts to build out from the back and counter against the hosts. The visitors showed more attacking ideas, but their execution was lacking and this one was decided early in the second half as the away defence sagged and Alessia Russo powered the ball home unmarked.

Arsenal’s gritty win over rivals Tottenham helps keep Russo & Co. within touching distance of the league lead. David Price/Arsenal FC via Getty Images

As the game opened up, the heavy tackles and fouls began to mount and the match devolved into a chippy affair, with Russo’s goal the difference. For Arsenal, the nature of the win was less important than their ability to finally claim a win over Spurs this season and keep pace with the top two (Manchester City and Chelsea) in the WSL title race. — Lawson

PSV getting closer to the title

EINDHOVEN, Netherlands — It wasn’t quite the coronation PSV had in mind, but Sunday’s 2-2 draw with Feyenoord means the hosts can start planning their title celebrations with a little more urgency. With 10 matches left, PSV remain undefeated in the Eredivisie this season and hold a 10-point lead over Feyenoord in second. From here, this should be a procession to their 25th Dutch title.

U.S. men’s international Malik Tillman was named player of the match after an impressive, all-action showing that included scoring PSV’s opener. It was a brilliantly worked solo goal, too — one involving a nutmeg of David Hancko — to give the hosts the lead after just three minutes. Feyenoord went into the break at 1-1 thanks to Yankuba Minteh seizing on dismal defending by Olivier Boscagli and then took the lead in the second half, with Santiago Giménez tapping home from close range in the 59th minute after a brilliant ball across the box from Lutsharel Geertruida. But PSV maintained their unbeaten league record with substitute Guus Til side-footing home a neat volley in the 69th minute, after some impressive hold-up play from Luuk de Jong to tee him up.

From a U.S. perspective, Tillman’s showing will be the headline act as he was a constant threat in the attacking third. He switched between pressing as a “forward 2” with De Jong and playing in the No. 10 attacking midfield spot. He could have added a second in the first half, too, but for a good save from Timon Wellenreuther to push a placed shot onto the post. Elsewhere, Sergiño Dest’s crosses caused all sorts of difficulties in the Feyenoord box while on this occasion, Ricardo Pepi remained on the bench.

But this was about PSV maintaining their invincible season and nullifying any potential late chase from Feyenoord. PSV looked comfortable and with 10 matches left in the season, they are edging ever closer to being named in the same breath as the 1919 and 1995 Ajax teams, who also went a whole season undefeated. — Tom Hamilton

Americans abroad: Tillman scores for PSV, Johnny shows up for Betis

play

0:45

USMNT’s Tillman nutmegs defender before scoring for PSV vs. Feyenoord

Malik Tillman puts PSV 1-0 up in a crucial top of the table clash vs. Feyenoord in the Eredivisie.

Sunday was another mixed bag of a day for U.S. talent in Europe, but a couple of players did show their best. (Another, Catarina Macario, also made a splash … but more on her later.)

Let’s begin with Malik Tillman. As noted above by Tom Hamilton, PSV are ticking closer to a first Eredivisie title since 2017-18 and in Sunday’s 2-2 draw with Feyenoord, it was Tillman opening the scoring with a fine strike, seen above.

Elsewhere, Real Betis midfielder Johnny Cardoso was given an assist for laying off the ball to William Carvalho, who thundered the ball in from distance, though it ended up being a consolation as Atletico Madrid hung on for a 2-1 win. In Italy, Tim Weah was a second-half sub for Juventus as they lost on the road at Napoli, while Weston McKennie remained on the sideline with a minor injury. — Tyler

News of the day

And finally, on Sunday …

Making her return to the pitch 641 days after rupturing an ACL, U.S. international Catarina Macario crowned both her comeback and Chelsea debut with a goal just six minutes after entering the fray.

CAT MACARIO SCORES ON HER DEBUT FOR CHELSEA AND LOOK HOW MUCH IT MEANS 💙🥹 pic.twitter.com/07qkWS62Ml

— Attacking Third (@AttackingThird) March 3, 2024

The goal, Chelsea’s fourth in a dominant display at Leicester City, capped a comprehensive win for the WSL leaders and came fully eight months after the U.S. forward made the switch to the Blues from French side Lyon. She made a clever off-the-ball run that opened up space to receive Agnes Beever-Jones’ sharp through-ball, after the England midfielder’s surging run to the edge of the box. After a cushioned first touch, Macario was able to wrap her foot around the ball and curl it between Julie Thibaud’s legs and beyond goalkeeper Lize Kop, leading to joyous team celebrations given the significance of her goal.

It was just the start Macario could have hoped for as she works her way back to full fitness and, we expect, a full return to the U.S. national team. — Lawson

SATURDAY REVIEW

The lead: Vini’s chaotic return to Mestalla

Real Madrid’s 2-2 draw at Valencia on Saturday should have been all about Vinicius, scoring twice at the stadium where he was racially abused last season. Instead, a chaotic finale saw Madrid’s players furious at referee Jesus Gil Manzano, who blew the full-time whistle just as Jude Bellingham was heading the ball into the net for what would have been the winning goal at Mestalla. Bellingham was even sent off for dissent in the aftermath. Coach Carlo Ancelotti called it “unprecedented.”

Real Madrid’s season-long unhappiness with referees might have just hit a new low.

Before that, the star was Vinicius. These weren’t the prettiest two goals he’s ever scored, far from it, but they might have been among the most significant to him. Madrid had trailed early, 2-0 down after half an hour thanks to two defensive mistakes — one of them from Vinicius himself — but with so much time left on the clock, the prospect of a comeback was never far away.

Editor’s Picks

2 Related

That comeback started with Vinicius, with 49 minutes and 50 seconds played, and 10 seconds left before halftime was due. The Brazil international had been whistled every time he touched the ball, but when Dani Carvajal’s cross was deflected into the six-yard box, Rodrygo got the faintest touch, and Vinicius was there to deflect it in with his shin. He picked the ball up, ran back towards the centre circle, turned and raised a single clenched fist to the crowd in a gesture of defiance.

It was a relatively restrained celebration, given the circumstances. What followed the second goal was a different story. It was another close-range finish, Vinicius’ header in the 76th minute making it 2-2. This time he cupped his ears, enjoying the crowd’s whistles, and pointed to his name on the back of his shirt.

There was time for Valencia to be awarded a 90th-minute penalty, overturned after a lengthy VAR review, before the moment of controversy. Real Madrid, pushing for a winner, had a corner. When the ball was cleared, referee Gil Manzano moved to blow his whistle, but he hesitated. Then, when he finally blew up, it was too late. Brahim Díaz was already crossing for Bellingham to score.

As Gil Manzano signalled that the game was over, rather than that a goal had been scored, he was surrounded by Real Madrid’s players, stunned. They had drawn a game they could have lost, but in the end, should have won. Their only consolation: a seven-point lead at the top of the LaLiga table, with rivals Girona and Barcelona playing on Sunday.

“We’ll look at the table, and we’ll sleep well,” Ancelotti insisted. — Alex Kirkland

Real Madrid were denied a late winner at Valencia following a very controversial referee’s decision. Mateo Villalba/Getty Images

Saturday talking points around the leagues

Mbappé sub overshadows showdown between PSG, Monaco

Don’t be fooled by Friday’s scoreline. The clash between AS Monaco, third in the table, and leaders Paris Saint-Germain finished goalless, but it was one of the best 0-0 draws we have seen this season in Europe. It was intense, chances were created, the tactical battle between Luis Enrique and Adi Hütter was fascinating and in the end, as the Spanish manager said, the draw is probably fair, even if Gianluigi Donnarumma was the busier of the two keepers.

However, the biggest talking point — and all everyone is talking about — is the substitution of Mbappé after just 45 minutes. In seven years in Paris, it had never happened before. Some wondered if perhaps the 2018 World Cup winner was injured, but no, it was a decision from the coach, which he explained quite clearly after the game.

“Sooner rather than later, we will play without Mbappé, so I’m looking for the best option for the team,” Luis Enrique said. “Sometimes I’m right, sometimes I’m wrong. We need to get used to [playing without Mbappé]. I will do what is best for my team. I don’t want to create controversy, it’s my decision.”

LIVE ON ESPN+ (SELECTED GAMES)

The beautiful game lives here. Stream top leagues, tournaments and teams.
Sign up for ESPN+

SUNDAY, MARCH 3 (all times ET)
• Ajax vs. FC Utrecht (6:15 a.m.)
• Villarreal vs. Granada (8 a.m.)
• PSV Eindhoven vs. Feyenoord (8:30 a.m.)
• Cologne vs. Bayer Leverkusen (9:30 a.m.)
• Atlético Madrid vs. Real Betis (10:15 a.m.)
• Hoffenheim vs. W. Bremen (11:30 a.m.)
• Mallorca vs. Girona (12:30 p.m.)
• Athletic Club vs. FC Barcelona (3 p.m.)

Even if Mbappé was not playing well against his former club, he is still PSG’s best and most decisive player by far, so taking him off was a huge call. The sort of call the inevitably creates controversy.

Mbappé’s decision not to sit on the bench after his substitution, and instead sit next to his mum in the stands, sparked even more controversy. It was not the right attitude to adopt for the captain on the night, even if his disappointment was understandable.

On Saturday morning, the two men had a long chat at the training ground. They cleared the air and Luis Enrique told his No. 7 that there was nothing personal and that it was not a punishment after Mbappé decided to leave the club.

Mbappé doesn’t have to believe him. Neither do we. — Julien Laurens

Bayern clear Leverkusen’s path to title

While Bayer Leverkusen are several weeks away from being able to mathematically clinch the German championship, Xabi Alonso’s side could make a major step towards the Bundesliga title thanks to Bayern Munich drawing with SC Freiburg on Friday.

The latest setback for Thomas Tuchel and his players was reminiscent of previous instances of dropped points, as Bayern looked incapable of converting their long spells of possession into goal-scoring opportunities. Instead, hosts Freiburg exposed some of the Bavarians’ defensive weaknesses, most notably their tendency to be stretched across the field. Freiburg used quick lateral passes to open the half-spaces and then explosively play through the gaps to set up chances for Lucas Höler and his teammates.

play

0:45

USMNT’s Tillman nutmegs defender before scoring for PSV vs. Feyenoord

Malik Tillman puts PSV 1-0 up in a crucial top of the table clash vs. Feyenoord in the Eredivisie.

After conceding just 12 minutes in, Bayern could not immediately turn the tide but instead needed a corner kick to score the equaliser that came courtesy of Mathys Tel. The young French forward and Jamal Musiala were the only bright lights in an otherwise underwhelming Bayern side. It was also Musiala who netted to give the visitors a 2-1 lead in the 75th minute, a goal that offered the record champions hope of leaving Freiburg’s Europa-Park Stadion with three points despite their poor performance.

Not this time. Höler put a stamp on his strong showing by scoring the decisive 2-2 equaliser three minutes before stoppage time, as Bayern defended a throw-in quite poorly.

Tuchel came under fire after the game for this decision to take Musiala and Thomas Müller off the pitch shortly after his team had taken the lead. His decision backfired and leaves Bayern ten points behind Leverkusen who will travel to FC Cologne on Sunday. — Constantin Eckner

Americans abroad: Not the best Saturday

Let’s start with the best news: Josh Sargent scored the lone goal in Norwich City’s 1-0 win over Sunderland in the English Championship. After missing 22 games through an ankle injury this season, the 24-year-old now has 11 goals in 15 league appearances, scoring at a rate of a goal per 88.9 minutes.

1️⃣1️⃣ in 1️⃣5️⃣ 🫡 pic.twitter.com/ispNoPPVR3

— Norwich City FC (@NorwichCityFC) March 2, 2024

The good news: Antonee Robinson went the full 90 minutes in Fulham’s 3-0 win over Brighton & Hove Albion. It’s the first clean sheet the Cottagers have kept since a Jan. 30 scoreless draw with Everton.

The not-so-good news: Chris Richards played the entirety of Crystal Palace’s 3-1 defeat at Tottenham Hotspur. Kevin Paredes started at left wing and featured for 81 minutes of VfL Wolfsburg’s 3-2 loss to VfB Stuttgart. Brenden Aaronson came off the bench for a 21-minute cameo as Union Berlin fell 2-0 at home to Borussia Dortmund.

The not-great news: Joe Scally didn’t get off the bench as Borussia Monchengladbach drew 1-1 at Mainz, but that’s less concerning than it first appears. This is the first time all season he hasn’t featured for the Foals.

And the worst news comes from Nottingham Forest, who lost to Liverpool in stoppage time. For the fifth straight match, Matt Turner was an unused substitute, while Giovanni Reyna — who has played just 39 minutes since making a January loan switch from Dortmund — wasn’t in Forest’s matchday squad while he recovers from a reported minor knock. — Austin Lindberg

News of the day

  • A large section of Chelsea’s fans vented their anger at the club’s American owners and coach Mauricio Pochettino on Saturday as the stuttering Blues struggled to a 2-2 draw at an injury-depleted Brentford. First came the shouts of “Roman Abramovich, Roman Abramovich” as fans sought to contrast their successes under the club’s former Russian owner with their mid-table position now. Then came a vitriolic chant about Todd Boehly, the most prominent face of Chelsea’s new ownership, another celebrating former manager Jose Mourinho, who won three league titles at Stamford Bridge, and finally a crude one about Pochettino, the former Tottenham Hotspur manager who was appointed as head coach of the west London club in May.

  • Paris Saint-Germain forward Kylian Mbappé met with manager Luis Enrique at the club’s training centre on Saturday to address tension stemming from the Spanish coach substituting his star player in recent games, sources told ESPN. Mbappé was taken off after the first half of Friday’s 0-0 draw with Monaco having been subbed off after 65 minutes of PSG’s draw with Rennes the week prior. Sources told ESPN that Mbappé, 25, was unhappy to be subbed off and asked to speak with Luis Enrique to address the matter, and the coach told him that it was nothing personal and not retribution for the striker’s reported decision to leave PSG.

  • Juventus manager Max Allegri has said he is sorry on a human and footballing level for Paul Pogba after the France midfielder received a four-year ban for doping on Thursday from Italian authorities. “I wrote him a message two days ago,” Allegri said. “On a human level I’m very sorry, but also from a footballing point of view. This sport is losing an extraordinary and difficult to find player who I had the pleasure of coaching. On top of that, Paul is also a very good person.”

And finally, on Saturday …

Just look at what it means … We’ve all heard the phrase, but it’s become so cliched that often the meaning is diluted. Not here.

For fans of the Cleveland Browns or the Charlotte Hornets or the Minnesota North Stars, you’ll know what it means when the Baltimore Ravens or the New Orleans Pelicans or the Dallas Stars come to town. That’s how AFC Wimbledon supporters feel when they take on MK Dons.

A MEMORY TO LAST A LIFETIME ❤️#AFCW 🟡🔵 pic.twitter.com/lzGKCLOfGU

— AFC Wimbledon (@AFCWimbledon) March 2, 2024

That’s because Wimbledon FC, founded in 1889, left southwest London for Milton Keynes, 45 miles to the northwest of the English capital, in 2004 to become MK Dons. AFC Wimbledon was founded in the aftermath of that decision, reaching the Football League in 2011.

So you can understand why Ronan Curtis’s 94th-minute winner, which saw the Dons’ hopes for promotion to League One take a hit, was celebrated so wildly by the Wimbledon fans at Plough Lane. — Lindberg

Categories
Science

Curiosity Rover is Climbing By Dramatic Striped Terrain on Mars

Just about every day we here on Earth get a breathtaking picture of Mars’s terrain sent back by a rover. But, the view from space can be pretty amazing, too. The Mars Reconnaissance Orbiter (MRO) just sent back a thought-provoking picture of Curiosity as it makes its way up a steep ridge on Mount Sharp.

The rover is a tiny black dot in the center of the image, which gives a good feeling for what MRO’s HiRISE camera accomplished. For scale, the rover is about the size of a dinner table, sitting in a region of alternating dark and light bands of material on the Red Planet.

NASA’s Curiosity Mars rover appears as a dark speck in this image captured from directly overhead by the agency’s Mars Reconnaissance Orbiter, or MRO. Credit: NASA/JPL-Caltech/University of Arizona

Where’s Curiosity?

The Curiosity rover is exploring an ancient ridge on the side of Mount Sharp, which is the peak of a crater on Mars. It’s sitting on the side of a feature called Gediz Vallis Ridge, and the terrains and materials preserve a record of what things were like when water last flowed there. That happened about three billion years ago. The force of the flow brought significant amounts of rocks and debris through the region. They piled up to form the ridge. So, much of what you see here is the desiccated remains of that flooding.

Debris flows are pretty common here on Earth, particularly in the aftermath of floods, volcanic eruptions, tsunamis, and other actions. We can see them wherever material floods through a region or down a slope. In a flood-based flow, the speed of the water combines with gravity and the degree of slope to send material rushing across the surface. A debris flow can also be a dry landslide, and those can occur pretty much anywhere on Earth where the conditions are right. Another type of debris flow comes from volcanic activity. That occurs when material erupts from a volcano, or when earthquakes combined with an eruption collapse material into the side of the mountain. That results in what’s called a “lahar”. Folks in North America might recall the Mount St. Helens eruption in 1980; it resulted in several lahars that buried parts of the surrounding terrain.

Now that scientists see similar-seeming regions on Mars, they want to know several things. How did they form? Were they created by the same processes that make them on Earth? And, how long ago did they begin to form? Curiosity and Perseverance and other rovers and landers have been sent to Mars to help answer those questions.

Understanding the Debris Ridge

Did any of these actions happen on Mars? The evidence is pretty strong, which is why Gediz Vallis itself is a major exploration goal for the rover. It’s a canyon that stretches across 9 kilometers of the Martian surface and is carved about 140 meters deep. Gediz was likely carved by so-called “fluvial” activity (meaning flowing action) in the beginning. Later floods deposited a variety of fine-grained sands and rocks. Over time, winds have blown a lot of that material away, leaving behind protected pockets of materials left behind by the flooding. The size of the rocks tells something about the speed of the flows that deposited all the material. Geological studies of those rocks will reveal their mineral compositions, including their exposure to water over time.

The Gediz Vallis ridge resulted from the action of water pushing rocks and dirt around to build it up over time. Planetary scientists now need to figure out the sequence of events that created it. The clues lie in the scattered rocks in the region and the surrounding terrain. Mount Sharp itself (formally known as Aeolis Mons), is about 5 kilometers high and is, essentially, a stack of layered sedimentary rocks. As Curiosity makes its way up the mountain, it explores younger and younger materials.

NASA’s Curiosity captured this 360-degree panorama while parked below Gediz Vallis Ridge (seen at right), a formation that preserves a record of one of the last wet periods seen on this part of Mars. After previous attempts, the rover finally reached the ridge on its fourth try. Credits: NASA/JPL-Caltech/MSSS.

Curiosity’s Mission at Gediz

To put all this on a larger scale, Mount Sharp is the central peak of Gale Crater. It formed some 3.5 to 3.8 billion years ago from an impact. As time went by, water flooded the crater several times. It flowed out and eventually disappeared as Mars’s climate changed it to the dusty desert we see today.

Winds also played a role in filling the crater with dust and sand deposits. This so-called aeolian activity also helped carve out Mount Sharp. This history of wind- and water-based deposition and erosion made Gale Crater a very attractive place to explore. That’s why Curiosity was sent there and continues its journey up Mount Sharp.

For More Information

HiRISE Spots Curiosity Driving Toward Upper Gediz Vallis
Curiosity Views Gediz Vallis Ridge
The Gediz Vallis Inverted Channel: Evidence for Late-state Flow in Gale Crater, Mars?

Like this:

Like Loading…

Categories
Technology

Docs have began prescribing a brand new medical therapy: a strolling app

Walking is the simplest form of exercise, but it has enormous benefits. As our lifestyles become ever more sedentary, doctors are increasingly prescribing walks to address medical conditions and our general wellbeing.

But how can patients stay motivated to keep it up? And how can doctors keep track of their progress? That’s where Lithuanian startup Walk15 comes in.

Founded in 2019, Walk15 is on a mission to engage people in physical activity. It provides a platform and an app, which companies and individuals can use to create and participate in step challenges, use their steps to unlock exclusive discounts, and analyse activity data.

The startup has built Lithuania’s largest fitness community, engaging 20% of the country’s population. It counts over 625,000 app users across the globe, while 1,300 companies are using its platform.

App users can track their daily steps, the distance walked in kilometres, and the calories burnt. They can also see how much CO2 they have saved by walking, visualised in virtual trees. With the Steps Wallet (on the right) users can turn their steps into product discounts from partners including IKI and NordSecurity.

The <3 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol’ founder Boris, and some questionable AI art. It’s free, every week, in your inbox. Sign up now!

Today, Walk15 is taking the biggest step yet in its journey. In a pilot called Personal Prescription Steps, the startup is combining its tech with public healthcare services.

“We’ll be like a pharmacy for walking.

A partnership with the Šeškinės clinic in Vilnius, the project is designed to help patients increase their physical activity and measure their performance. The initiative will provide personalised doctor recommendations on the number and type of steps they need to take.

“We will be like a pharmacy for walking,” co-founder and CEO Vlada Musvydaitė-Vilciauske tells TNW. The partnership, she adds, “can bring real change.” Not only can it expand the benefits of exercise, but it can also support the digital transformation of entire healthcare systems.

The idea of the steps prescription came to Musvydaitė-Vilciauske four years ago during a project with a pharmaceutical company. “I had a question then — why do we write prescriptions to get well? Why don’t we write a prescription so we don’t get sick?” she explains.

How does the Personal Steps Prescription work?

The process is very simple. Doctors at the Šeškinės clinic will provide patients with a steps prescription with a specific activity target over a set amount of time — depending on the individual’s health conditions.

Doctors can issue the prescription in the form of a challenge using Walk15’s platform, while patients can access the challenge in the app via a link or QR code.

I got a personalised sample prescription for myself. This is what it looked like:

Walk15 steps prescription

Embarrassingly, I didn’t meet the goal every single day, but on some days I completed as many as 13,000 to 16,000 steps.

I also noticed a significant improvement: I became more aware of how sedentary my lifestyle is. And the closer I was to reaching the goal, the more motivated I felt.

Being someone who’s dealing with a couple of health issues myself, my motivation would have been even higher if I knew that this was a recommendation from my doctor.

A key aspect of this tool is that doctors have access to the patient’s activity. When the prescription expires, they receive an automated report with the users’ progress and can see whether the goal has been achieved. Then doctors can evaluate the results alongside the patients’ overall health assessment and determine whether the prescription needs to be renewed or changed.

Patients also receive notifications on their phone with professional content prepared by doctors of the Šeškinė clinic as well as professors and scientists from the Lithuanian Sports University.

Musvydaitė-Vilciauske explains that this can include information about chronic disease prevention, for instance, or about exercises that alleviate anxiety. She stresses that the pilot’s aim is to also educate patients on physical activity and wellness.

Meanwhile, to boost motivation, patients can use the Steps Wallet feature to exchange their steps for benefits such as a body mass index test.

Take a walk, not a pill

“Let’s talk numbers,” Musvydaitė-Vilciauske says. “Sufficient daily physical activity fights against more than 40 chronic diseases, and also helps those already suffering from them.”

Medical research shows that exercise can indeed have benefits equivalent to pharmacological treatments. Walking, in particular, can reduce the risk of multiple chronic illnesses, including asthma, type 2 diabetes, and strokes.  It is also associated with improved mental health and lower levels of stress and anxiety.

In addition, studies have also found that walking can improve cardiovascular health and decrease the risk of dementia or even some types of cancer more effectively than any pill.

Prevention is key not only to enabling a healthier, longer life, but also to alleviating the pressure on our overburdened healthcare systems.

To put this into perspective, cardiovascular diseases (CVDs) are the leading cause of death globally, according to the World Health Organisation. At the same time, CVD alone is estimated to cost the EU €282bn per year, with health and long-term care accounting for €155bn — 11% of the bloc’s total health expenditure.

Musvydaitė-Vilciauske believes that Walk15’s solution is a time- and money-saving technology with benefits for individuals, healthcare services, and governments alike.

Vlada Musvydaitė Walk 15Vlada Musvydaitė- Vilciauske , co-founder and CEO at Walk15. Credit: Walk15

“We will act like the new virtual pharmacy, where medicines are prepared with the help and findings of the best professors [and] doctors,” she says.

“Our pharmacy will produce medicines that will help those who want to lose weight, manage stress, headaches, and ageing processes — the only difference is that the component of our medicines is not chemistry, but sustainable active mobility.”

The first steps prescriptions for Šeškinė clinic’s patients will start on March 15, initially for the prevention of cardiovascular diseases for the 40-60 age group.

If the pilot is successful, it has the potential to not only contribute to disease prevention and a healthier lifestyle, but also normalise walking as a means of medical treatment. “People go to the pharmacy and buy ibuprofen of 1,000mg,” Musvydaitė-Vilciauske says. “But what if that was 5,000 steps instead?”

Categories
Entertainment

Oklahoma College Beneath Investigation For Toe-Sucking Competitors

A high school in Oklahoma is under investigation after a viral video shows students licking and sucking another participant’s toes at a school-sanctioned event.

The Post reports, Deer Creek High School held a fundraiser inside the institutions gym. At least four teens laid on their stomaches as they vigorously ate peanut butter off of another participant’s bare feet. It is unclear if the other party adorning the peanut were students or adults.

RELATED: Investigation Launched After Viral Video Shows Parent Threatening Students On A School Bus After He Claims His Child Was Hit By Another Student 

In the disturbing video, students can be heard cheering as the kids used their mouths to remove the peanut butter.

Additionally, one student in the background says, “He is devouring those!” Moreover, a moderator can be heard hyping up the crowd and contestants.

A Bad Idea For A Good Cause

The incident occurred on Thursday at the school’s ‘Clash of Classes’ assembly. According to the Deer Creek School District, the event was one of several during the week designed to raise money for a local coffee shop that hires people with special needs.

The toe-sucking tournament was an event that students paid to attend. Teenagers grades 9th through 12th volunteered to participate in the activities.

Initially, administrators were down with the vomit-worthy contest and praised students for their participation in the ‘Wonderful Week’ of fundraising. The student body raised a total of $152,830.38. But after the peanut butter hit the fan, they apologized to its students and parents.

🚨GRAPHIC WARNING- Video sent to FOX 25 shows students at Deer Creek High kissing and sucking on feet yesterday. @DCAntlers confirms the video, saying the students volunteered in challenges to help raise money for their annual philanthropy week. More at 9pm tonight on @OKCFOX. pic.twitter.com/3FaG8BbeAE

— Wendy Suares📺 (@wsuares) March 1, 2024

In just 24 hours, the video of the bizarre competition has accumulated nearly 50 million views. After the Oklahoma State Department of Education took notice, a formal investigation was implemented.

What’s The School District’s Response To This Sticky Situation?

Superintendent Ryan Walters said on X, “This is disgusting. We are cleaning up this filth in Oklahoma schools. Our agency is investigating.”

This is disgusting. We are cleaning up this filth in Oklahoma schools. Our agency is investigating. https://t.co/XdWGFy3Hc2

— Superintendent Ryan Walters (@RyanWaltersSupt) March 2, 2024

In a statement to The Post, the school district said, “There is a video circulating on social media of one of the activities that involves students only during this assembly that has, unfortunately, gained national attention.”

“We want to stress to our community that much of the information accompanying this video is inaccurate. However, through this specific game we failed to uphold the dignity of our students and the proud image of our community. We have a responsibility to protect our Antlers and showcase them in a positive light. In regards to this one particular activity, we fell short and for that we greatly apologize.”

Furthermore, the school district stated, “Thank you for standing with us and helping us to weather this storm and move forward together.”

Texas Senator Ted Cruz categorized the competition as “child abuse” on X, to which Walters responded, “Completely agree. We are stopping this in Oklahoma.”

This is child abuse. https://t.co/wva8n5GEcG

— Ted Cruz (@tedcruz) March 1, 2024

The Department of Education’s investigation has not yet been concluded.

RELATED: Atlanta Public Schools Investigate High School Football Staff After Volunteer Coach Is Filmed Punching Student Athlete (Video)

Categories
Health

Viking Therapeutics emerges as competitor

Cr | Istock | Getty Images

Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. 

Viking is just one of several companies racing to join the growing space. Some analysts say the market could be worth $100 billion by the end of the decade.

Viking aims to compete with injectable drugs from Eli Lilly and Novo Nordisk. Their treatments sparked the weight loss drug industry gold rush over the past year despite their hefty price tags and barriers to insurance coverage. 

Some Wall Street analysts said Viking’s experimental obesity treatment may be “best-in-class.” In a midstage trial, an injectable version of Viking’s drug appeared to promote even greater weight loss than Eli Lilly’s Zepbound.

Viking gave a first glimpse at data from that study on Tuesday, and its shares soared 120%. The promising results make the company an impressive potential player in a market that will likely have room for more entrants in the coming years. 

Goldman Sachs projects that between 10 million and 70 million Americans will be taking weight loss drugs by 2028. Eli Lilly and Novo Nordisk have also struggled to offer enough supply of their treatments, giving other companies a chance to win market share.  

The new data also makes Viking a more attractive deal target for larger companies trying to break into the space or expand their obesity treatment offerings.

It’s too early to say whether Viking’s drug could have an edge over existing or developing weight loss treatments. It’s difficult to compare therapies without pitting them head to head in the same clinical trial. 

Viking also needs to conduct a late-stage study on its drug, and likely won’t launch the injection until the later part of the decade. The small company faces hurdles to entering the market, such as manufacturing enough of the drug to meet booming demand. But an acquisition by a larger company could help solve some of those issues.

Data suggests Viking’s drug may have an edge

Viking’s phase two trial followed more than 170 patients who are overweight or obese. They received different dose sizes of the injectable drug or a placebo.

The trial did not directly compare Viking’s treatment to other drugs. Still, many analysts compared Viking’s injection to Eli Lilly’s Zepbound, largely because they work the same way. 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.

Brendan Mcdermid | Reuters

Both drugs imitate two naturally produced gut hormones called GLP-1 and GIP. GLP helps reduce food intake and appetite. GIP, which also suppresses appetite, may also improve how the body breaks down sugar and fat.

Meanwhile, Novo Nordisk’s weight loss injection Wegovy only targets GLP-1. 

Analysts were particularly impressed by the weight patients lost after they took the highest dose of Viking’s drug. Those who received a weekly 15 milligram dose of the treatment lost 13.1% of their body weight on average after 13 weeks compared to those who took the placebo. 

Notably, there was no evidence of a plateau in weight reduction at week 13 for any dose of the drug. That suggests that “further weight loss might be achieved” by keeping patients on the treatment longer, Viking CEO Brian Lian said during a call with investors on Tuesday.

Viking’s drug data shows a “best-in-class profile” among both approved and experimental weight loss drugs with phase two trials, William Blair analyst Andy Hsieh wrote in a note Tuesday. Eli Lilly’s Zepbound generated roughly 7% weight loss relative to a placebo after 12 weeks in a phase three clinical trial, Hsieh noted.

Viking’s drug also appears to top Novo Nordisk’s weight loss injection Wegovy, according to a separate Tuesday note from BTIG analysts.

Based on chart data from a phase three trial, the analysts estimated that Wegovy caused around 5% weight loss at 13 weeks compared to a placebo.

Meanwhile, several analysts estimated that some doses of Eli Lilly’s experimental injection, retatrutide, caused between 9% and 13% weight loss relative to a placebo at 13 weeks based on chart data from a midstage trial.

The majority of adverse side effects that patients experienced after starting Viking’s drug were mild or moderate. Many of those instances were gastrointestinal, which is common across all weight loss and diabetes treatments.

Around 20% of patients who took the 15 milligram version of Viking’s drug discontinued treatment early in the study. That compares with around 14% of those taking the placebo who stopped early in the trial. 

But Jefferies analyst Akash Tewari wrote in a note Tuesday that Viking’s trial used faster “titration” in patients. That refers to increasing the dose size a patient takes over time until they reach a target dosage level. 

He said Viking may be able to make its drug easier for patients to tolerate in a future trial with slower titration, which could potentially lower the treatment’s efficacy. 

Viking still has a long way to go

Despite the compelling data, Viking has far more work to do before it can compete in the weight loss drug market. 

The company plans to meet with the U.S. Food and Drug Administration later this year to discuss a clinical development plan for the treatment. 

Viking CEO Brian Lian told investors on a call Tuesday that the company will likely conduct another phase two trial that could last six to nine months.

Jefferies’ Tewari estimates that Viking’s treatment won’t reach the market until 2029 or later. A late-stage trial on the drug could be lengthy. Eli Lilly’s phase three study on Zepbound lasted two and a half to three years.

The late entrance of Viking’s drug is one reason why Tewari doesn’t believe the company will meaningfully cut into Eli Lilly’s market.

The pharmaceutical giant could also launch a slate of other weight loss treatments over the next few years that may have advantages over Zepbound, whether they offer more weight loss or convenience. They include Eli Lilly’s experimental pill orforglipron and the widely watched retatrutide, which mimics three gut hormones instead of two. 

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey, on March 5, 2021.

Mike Segar | Reuters

Analysts from Deutsche Bank added in a note Tuesday that manufacturing the treatments “at scale to meet outsized demand has proven to be no easy feat.” They said that gives Eli Lilly and Novo Nordisk a “defensive moat” against rivals.

Viking acknowledged this hurdle on the call Tuesday. Lian said the company has enough supply of the drug to support its clinical trials, but its manufacturing capacity is insufficient for a commercial rollout. 

But Lian noted that the company is “spending a lot of time” evaluating multiple manufacturing processes to understand “what’s fastest, what’s highest yielding, what’s cheapest and what’s most scalable.” 

Partnerships, buyouts are on the table 

Viking’s impressive data could make it an attractive target for a takeover or partnership with a large pharmaceutical company. That could give Viking the commercial and manufacturing capabilities needed to compete in the weight loss drug market. 

William Blair’s Hsieh added that large pharmaceutical companies could maximize the value of Viking’s treatment because they could better navigate the rebate and reimbursement landscape for weight loss drugs.

Some analysts expect other companies to have high interest in Viking.

“This very well could be on the shopping list for any large-cap pharma or biotech company that wants to be in the obesity market but currently doesn’t have a drug. There are plenty of them out there,” Oppenheimer analyst Jay Olson told CNBC. 

He added that a company could “pay a pretty significant premium for Viking and pick this up … for a relatively low price compared to the potential that exists for a drug like this.” As of Friday, Viking had a market cap of more than $8.5 billion.

Injection pens of Novo Nordisk’s weight loss drug Wegovy are shown in this photo in Oslo, Norway, on Nov. 21, 2023.

Victoria Klesty | Reuters

Viking is an appealing deal target because of more than just the new data. Wall Street is eager for the company to release early-stage trial results on an oral version of its weight loss treatment this quarter. 

The BTIG analysts noted that the intellectual property coverage for both versions of the drug extends beyond 2040, “boding well” for potential partnership discussions. 

Viking also has other drugs in development, including a promising oral treatment for a certain form of liver disease. Eli Lilly, Novo Nordisk and other drugmakers are also racing to see whether their drugs can treat that same condition. 

Viking hasn’t disclosed any details about its discussions with potential partners. But the company has “always been open to partner discussions since day one, so we’re always opportunistically evaluating whatever is presented to us,” Lian said during Viking’s fourth-quarter earnings call last month. 

Other drugmakers have pursued deals over the past year to carve out a space in the weight loss drug market. 

Swiss company Roche said it would buy the privately held U.S. obesity drugmaker Carmot Therapeutics for $2.7 billion. AstraZeneca signed a licensing agreement with Chinese biotech company Eccogene to develop an obesity pill. 

Even Novo Nordisk and Eli Lilly have snapped up smaller obesity drug companies this year to maintain their dominance in the market.

Don’t miss these stories from CNBC PRO:

Categories
Science

Germany’s Unstable Energy Grid…Coal Vegetation Will Be Wanted “For A Very Lengthy Time” – Watts Up With That?

From the NoTricksZone

By P Gosselin

When green energy ideology clashes with the laws of Engineering and physics…

By KlimaNachrichten Editor

Manfred Haferburg, power plant engineer, explains the problems of the German power grid in connection with the green energy transition at online site Achgut. The result is a very informative article. It is not primarily about blackouts due to a lack of power.

The author begins by explaining three important terms: The n-1 criterion, reactive power and instantaneous reserve.

“Let’s translate all the technical gobbledygook. The experts at the power transmission grid operators have been ‘preoccupied”‘ with the topic for a long time, but politicians have not understood it because ‘it is a very complex issue’. And then comes the kicker: the German transmission grid can no longer cope with the ‘n-1 error’ in every case. This means that if, in a tense situation, one of the large transmission lines suddenly fails due to a lightning strike, long-wave conductor vibrations in high winds and snow, sabotage or a transformer/high-voltage switch fault, ‘the electricity grid could become unbalanced’ – in other words, it could collapse in a domino effect. This could result in a partial grid failure or, in the worst case, a blackout. This time it’s not me saying this, but the team leader for system behavior in the strategic grid planning department at TransnetBW. I wrote this on this site years ago and was berated for it.”

“Here, too, an attempt at layman’s language: the large rotating generators of the power plants are ‘grid-forming’ machines; due to their large mass, they keep the frequency of 50 Hz constant in the range of seconds. For our colleagues at the Feferal Ministry of Economics and Federal Grid Agency, inertia is a physical property that ensures that power fluctuations are cushioned in a range in which the time for human intervention is too short. Wind turbines have only small masses and solar panels have no rotating parts at all, they are ‘grid-following’ with their inverters; this means that they are connected to the grid of the ‘grid-forming machines’ and do not have a stabilizing effect. Incidentally, gas-fired power plants tend to be ‘grid-following machines’. The large power plant generators have also been responsible for maintaining the voltage in the grid through reactive power control.”

At the end of the article, Haferburg comes to the conclusion that we will continue to see coal-fired power plants in operation for a very long time.

Read the full article on Achgut.
(Note: Today’s modern translation tools do a pretty good job at translating the text into English)

4.8
6
votes

Article Rating

Like this:

Like Loading…

Categories
Sport

2024 March Insanity males’s discipline predictions

RULES

ESPN’s Bracketology efforts are focused on projecting the NCAA tournament field just as we expect the NCAA Division I basketball committee to select the field in March. ESPN bracketologist Joe Lunardi uses the same data points favored by the committee, including strength of schedule and other season-long indicators, including the NET and team-sheet data similar to what is available to the NCAA, in his projections of the field. Visit the NCAA’s website for a fuller understanding of NCAA selection criteria.

68-Team Bracket

The 68-team bracket is the standard version of the NCAA tournament field that has been in place since 2011. If the 2021 field is comprised of 68 teams, there will be some key differences to past years, however.

The primary adjustment from a normal year is, of course, the playing of the entire NCAA tournament at a single site. This eliminates the need for geographical considerations in seeding. Additionally, there will be at least one fewer automatic qualifier this season, as the Ivy League’s decision to forgo the 2020-21 season reduces the number of AQ entries to 31 for this season.

48-Team Bracket

In this projection, a condensed selection process would reduce the field by 10 at-large teams and 10 automatic qualifiers (the latter of which still receive a revenue unit). The top four seeds in each region would receive a bye into the second round, with four first-round games per region – 5 vs. 12, 6 vs. 11, 7 vs. 10 and 8 vs. 9 – being played without fans on the higher seed’s home court.

To minimize travel, first-round pairings will be guided by geography to the greatest extent possible. And the reduced field results in only 32 teams competing at the central site. All participants must post a minimum .500 conference record – the “Lunardi Rule” – for at-large consideration.

16-Team Bracket

In this projection, the committee selects and seeds the 16 best available teams. There are no automatic qualifiers, although all non-competing conference champions receive the designated revenue unit.

To maintain some sense of national balance, conference participation is capped at four teams. And no region shall have more than one team from the same conference.